Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma

Abstract excerpt

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths worldwide. Lung adenocarcinoma (LUAD) is one of the main subtypes of lung cancer. Hundreds of metabolic genes are altered consistently in LUAD; however, their prognostic role remains to be explored. This study aimed to establish a molecular signature that can predict the prognosis in patients with LUAD based on metabolic gene expression....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer, Hypoxia, and Metabolism
• Share to Cancer, Lipids, and Metabolism
• Share to Ferroptosis and cancer prognosis